TR201906742T4 - Tıbbi bir ürün ve tedavi. - Google Patents

Tıbbi bir ürün ve tedavi. Download PDF

Info

Publication number
TR201906742T4
TR201906742T4 TR2019/06742T TR201906742T TR201906742T4 TR 201906742 T4 TR201906742 T4 TR 201906742T4 TR 2019/06742 T TR2019/06742 T TR 2019/06742T TR 201906742 T TR201906742 T TR 201906742T TR 201906742 T4 TR201906742 T4 TR 201906742T4
Authority
TR
Turkey
Prior art keywords
ibuprofen
paracetamol
patients
pain
treatment
Prior art date
Application number
TR2019/06742T
Other languages
English (en)
Turkish (tr)
Inventor
Campbell Atkinson Hartley
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201906742(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of TR201906742T4 publication Critical patent/TR201906742T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
TR2019/06742T 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi. TR201906742T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14

Publications (1)

Publication Number Publication Date
TR201906742T4 true TR201906742T4 (tr) 2019-05-21

Family

ID=42106693

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2019/06742T TR201906742T4 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi.
TR2011/02810T TR201102810T2 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2011/02810T TR201102810T2 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi

Country Status (29)

Country Link
US (1) US20110166234A1 (https=)
EP (1) EP2341900B1 (https=)
JP (1) JP2012505830A (https=)
KR (1) KR20110112279A (https=)
CN (1) CN102215835A (https=)
AU (1) AU2009304002B9 (https=)
BR (1) BRPI0914086A2 (https=)
CA (1) CA2735834C (https=)
CH (1) CH702339B1 (https=)
CL (1) CL2011000678A1 (https=)
CO (1) CO6341553A2 (https=)
CY (1) CY1122198T1 (https=)
DK (1) DK2341900T3 (https=)
ES (1) ES2725151T3 (https=)
GB (1) GB2476418B (https=)
HR (1) HRP20190891T1 (https=)
HU (1) HUE043063T2 (https=)
LT (1) LT2341900T (https=)
MA (1) MA32635B1 (https=)
MX (1) MX340662B (https=)
MY (1) MY153932A (https=)
NZ (1) NZ591496A (https=)
PL (1) PL2341900T3 (https=)
PT (1) PT2341900T (https=)
RU (1) RU2487707C2 (https=)
SI (1) SI2341900T1 (https=)
TR (2) TR201906742T4 (https=)
WO (1) WO2010044681A1 (https=)
ZA (1) ZA201101752B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE543491T1 (de) 2004-07-07 2012-02-15 Aft Pharmaceuticals Ltd Kombinationspräparat enthaltend ibuprofen und paracetamol
US20130225685A1 (en) * 2010-11-04 2013-08-29 Aft Pharmaceuticals Limited Combination composition
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
CN114681324B (zh) * 2017-07-10 2024-05-03 盖尔凯普科技有限公司 双释放剂型胶囊及其制备方法、装置和系统
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
ATE543491T1 (de) * 2004-07-07 2012-02-15 Aft Pharmaceuticals Ltd Kombinationspräparat enthaltend ibuprofen und paracetamol
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
TR201102810T2 (tr) 2011-05-23
CH702339B1 (de) 2016-06-15
RU2487707C2 (ru) 2013-07-20
NZ591496A (en) 2012-12-21
KR20110112279A (ko) 2011-10-12
CO6341553A2 (es) 2011-11-21
ZA201101752B (en) 2012-02-29
GB2476418B (en) 2013-04-24
AU2009304002A1 (en) 2010-04-22
CA2735834C (en) 2017-05-16
WO2010044681A1 (en) 2010-04-22
MA32635B1 (fr) 2011-09-01
MX2011003928A (es) 2011-08-12
JP2012505830A (ja) 2012-03-08
PL2341900T3 (pl) 2019-08-30
ES2725151T3 (es) 2019-09-19
CN102215835A (zh) 2011-10-12
EP2341900A4 (en) 2012-02-29
AU2009304002B9 (en) 2014-06-26
SI2341900T1 (sl) 2019-06-28
EP2341900A1 (en) 2011-07-13
DK2341900T3 (da) 2019-05-20
EP2341900B1 (en) 2019-02-20
US20110166234A1 (en) 2011-07-07
CY1122198T1 (el) 2020-11-25
GB201105249D0 (en) 2011-05-11
MX340662B (es) 2016-07-20
HRP20190891T1 (hr) 2019-07-12
CA2735834A1 (en) 2010-04-22
BRPI0914086A2 (pt) 2020-01-21
GB2476418A (en) 2011-06-22
RU2011111792A (ru) 2012-11-27
PT2341900T (pt) 2019-05-14
CL2011000678A1 (es) 2011-09-23
LT2341900T (lt) 2019-04-10
HUE043063T2 (hu) 2019-07-29
MY153932A (en) 2015-04-15
AU2009304002B2 (en) 2013-04-18

Similar Documents

Publication Publication Date Title
JP7590803B2 (ja) 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
Barkin Topical nonsteroidal anti-inflammatory drugs: the importance of drug, delivery, and therapeutic outcome
Gruenthal et al. Gabapentin for the treatment of spasticity in patients with spinal cord injury
US6689399B1 (en) Transdermal delivery of an anti-inflammatory composition
KR20200055067A (ko) 성인의 초점성 뇌전증의 치료를 위한 합성 경피성 칸나비디올
TR201906742T4 (tr) Tıbbi bir ürün ve tedavi.
Oh et al. Comparative analysis of intra-articular injection of steroid and/or sodium hyaluronate in adhesive capsulitis: prospective, double-blind, randomized, placebo-controlled study
US20100226972A1 (en) Transdermal pain gel
RU2616520C2 (ru) Лечение симптомов, связанных с гастропарезом у женщин
Agarwal et al. Gabapentin enacarbil–clinical efficacy in restless legs syndrome
US20140037718A1 (en) Transdermal pain gel
Polacco et al. The effect of intra-articular hyaluronic acid (Sinovial® One) on knee osteoarthritis: A preliminary study
CN104906501A (zh) 治疗银屑病的中药组分组合物
Evcik et al. The efficacy of intra-articular tenoxicam in the treatment of knee osteoarthritis
WO2026035552A1 (en) Naproxen/pregabalin conjugate dosing regimen
Saha et al. Role of Glucosamine Sulphate, Chrondoitin Sulphate and Vitamin C in the management of pain in Osteoarthritis
Hohn et al. Effects of dextromethorphan on postoperative pain after orthopedic surgery under spinal anesthesia
Oates Complementary medicines for musculoskeletal conditions
CN108883056A (zh) 用于治疗外周关节、脊柱关节和/或结缔组织的细胞外基质元件的制剂、制造方法和用途
WO2016092377A2 (ru) Композиция, содержащая глюкозамин, фруктобарат кальция и витамин d для лечения и/или профилактики нарушений, связанных с воспалительными заболеваниями суставов, её применение и способ лечения и/или профилактики нарушений, связанных с воспалительными заболеваниями суставов и позвоночника